Due to the involvement of Rac1 in multiple human cancers, it was inferred that Myo7a could exert tumour-promoting phenotypes by promoting RhoGDI2 expression levels and consequently Rac1 activity in B16 melanoma [47]. This evidence concerns the gene RAC1 and neoplasm.